Achieved $479.0 million in AYVAKIT® (avapritinib) global net product revenues in 2024, including $144.1 million in the fourth quarter -- -- Anticipate global AYVAKIT net product revenue of ...
Collaboration will combine AbbVie's oncology expertise and Xilio's proprietary tumor-activation technology to develop novel immunotherapies, including masked T-cell engagersXilio to host investor ...
Bruker Corporation (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2024 financial results before market opening on Thursday, February 13, 2025. The Company will host a ...
The fourth international congress of West Asian and North African (WANA) countries is scheduled to be held from May 3-4 in ...
The Cell, Developmental and Molecular Biology graduate program offers world-class facilities and faculty in biochemistry, genetics, microbiology, cell biology, developmental biology. Ohio University ...
Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. In the digital age, AI-powered ...
Cell proliferation is the process that results in an increase of the number of cells, and is defined by the balance between cell divisions and cell loss through cell death or differentiation. Cell ...
The workforce reduction is expected to be substantially completed in the second quarter of 2025.
Understanding how cells transform into specialized types during human development is a central challenge in biology. This complex process, known as cell differentiation, holds the key to ...
The SNU BioTalk 2025 an International Conference, themed "Symphony of Cellular Signals in Metabolism and Immune Response," ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results